II
Calendar No. 510
116th CONGRESS
2d Session
H. R. 3153
[Report No. 116–248]
IN THE SENATE OF THE UNITED STATES
July 24, 2019
Received; read twice and referred to the Committee on Commerce, Science, and Transportation
August 6, 2020
Reported by Mr. Wicker, with an amendment
Strike out all after the enacting clause and insert the part printed in italic
AN ACT
To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes.
Short title; findings
Short title
This Act may be cited as the Expanding Findings for Federal Opioid Research and Treatment Act
or the EFFORT Act
.
Findings
The Congress finds that—
research gaps currently exist in the prevention and treatment of opioid addiction;
the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and
the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.
NSF support of research on opioid addiction
The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction.
Short title; findings
Short title
This Act may be cited as the Expanding Findings for Federal Opioid Research and Treatment Act
or the EFFORT Act
.
Findings
Congress finds that—
research gaps exist in the prevention and treatment of opioid addiction;
the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and
the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.
NSF support of research on opioid addiction
In general
The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively-awarded research on the science of opioid addiction.
Authorization of appropriations
To carry out this section, there are authorized to be appropriated $10,000,000 for each of fiscal years 2020 through 2024.
August 6, 2020
Reported with an amendment
